Researchers tested how well three antifungal drugs (micafungin, anidulafungin, and caspofungin) work against a common fungus that causes skin infections. They found that two of these drugs were more effective than the third, suggesting they could be helpful alternatives when standard treatments fail due to drug-resistant fungal strains. The study also reviewed similar research worldwide and found consistent results across different testing methods.